BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2024)

BeOne Medicines (ONC) has 8 years of Amortization - Intangibles data on file, last reported at $1.2 million in Q2 2024.

• On a quarterly basis, Amortization - Intangibles rose 14.49% year-over-year to $1.2 million in Q2 2024; TTM through Jun 2024 was $7.6 million, a 91.06% increase from a year earlier, with the FY2023 full-year figure at $7.2 million, up 82.07% from the prior year.
• Amortization - Intangibles for Q2 2024 stood at $1.2 million, down from $1.2 million in the prior quarter.
• Over the last five years, Amortization - Intangibles for ONC reached as high as $3.0 million in Q4 2023 and fell as low as $187000.0 in Q3 2020.
• Historically, Amortization - Intangibles has averaged $896444.4 across 5 years, with a median of $977500.0 in 2022.
• Across the five-year window, Amortization - Intangibles tumbled 43.5% in 2020 and surged 442.55% in 2022, its largest moves.
• Year by year, Amortization - Intangibles stood at $188000.0 in 2020, then jumped by 335.64% to $819000.0 in 2021, then climbed by 18.32% to $969000.0 in 2022, then surged by 205.16% to $3.0 million in 2023, then slumped by 60.2% to $1.2 million in 2024.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $1.2 million in Q2 2024, $1.2 million in Q1 2024, and $3.0 million in Q4 2023.